Skip to Content

Amrix Approval History

  • FDA approved: Yes (First approved February 1st, 2007)
  • Brand name: Amrix
  • Generic name: cyclobenzaprine
  • Dosage form: Extended-Release Capsules
  • Company: ECR Pharmaceuticals
  • Treatment for: Muscle Spasm

Amrix is an extended-release formulation of the skeletal muscle relaxant cyclobenzaprine, indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

Development History and FDA Approval Process for Amrix

DateArticle
Feb  1, 2007Approval Amrix Approved - ECR Pharmaceuticals - relief of muscle spasm associated with acute, painful musculoskeletal conditions

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide